TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

NCT06051253 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Infliximab
Perianal Fistula Due to Crohn's Disease
Therapeutic Drug Monitoring
Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score

Interventions

DRUG: TDM-based infliximab intravenous therapy
DRUG: Standard infliximab intravenous therapy

Sponsor

Asan Medical Center